From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

AIM Investor - a twitter moron who blames me for him losing money for investing in a fraud: Supply@ME Capital

By Tom Winnifrith | Thursday 30 July 2020


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Such are the stages of grief, those who have lost out seek folks to blame. Supply@ME Capital came to the market via an RTO at 0.68p on March 23 2020. Its prospectus was, at best, grotesquely misleading and, in my view, fraudulent, mistating both assets and the trading posution. Today we have published yet more shocking revelations and shares in the, almost insolvent, company languish at sub 0.05p to sell. They are worth 0p. So who is to blame for the losses suffered by morons like @Aimfatgreek who takes to twitter? Er…. you will never guess. Or maybe you have seen this play out before.

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:51:36